Yantai Dongcheng Pharmaceutical Co Ltd (002675) — Financial Flexibility Index
Yantai Dongcheng Pharmaceutical Co Ltd (002675) has a Financial Flexibility Index of 0.11x as of December 2025. Free cash flow of CN¥398.23 Million (operating CF CN¥239.54 Million minus capex CN¥158.69 Million) represents 0% of total liabilities (CN¥3.61 Billion). Check Yantai Dongcheng Pharmaceutical Co Ltd strategic capital allocation to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Yantai Dongcheng Pharmaceutical Co Ltd Financial Flexibility Index (2008–2025)
Historical Financial Flexibility Index trend for Yantai Dongcheng Pharmaceutical Co Ltd across 18 annual periods. See working capital position of Yantai Dongcheng Pharmaceutical Co Ltd to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Yantai Dongcheng Pharmaceutical Co Ltd (2008–2025)
Year-by-year free cash flow to debt coverage for Yantai Dongcheng Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see Yantai Dongcheng Pharmaceutical Co Ltd stock valuation.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.26x | CN¥945.43 Million | CN¥584.61 Million | CN¥3.61 Billion | ▲ +15.1% |
| 2024 | 0.23x | CN¥743.25 Million | CN¥287.15 Million | CN¥3.26 Billion | ▼ -22.4% |
| 2023 | 0.29x | CN¥788.89 Million | CN¥276.94 Million | CN¥2.69 Billion | ▼ -38.7% |
| 2022 | 0.48x | CN¥1.39 Billion | CN¥996.54 Million | CN¥2.89 Billion | ▼ -14.5% |
| 2021 | 0.56x | CN¥1.47 Billion | CN¥943.58 Million | CN¥2.63 Billion | ▲ +62.8% |
| 2020 | 0.34x | CN¥834.76 Million | CN¥572.58 Million | CN¥2.43 Billion | ▼ -8.6% |
| 2019 | 0.38x | CN¥946.45 Million | CN¥696.38 Million | CN¥2.52 Billion | ▲ +44.4% |
| 2018 | 0.26x | CN¥614.12 Million | CN¥493.06 Million | CN¥2.36 Billion | ▲ +46.5% |
| 2017 | 0.18x | CN¥352.86 Million | CN¥208.94 Million | CN¥1.98 Billion | ▼ -35.7% |
| 2016 | 0.28x | CN¥327.45 Million | CN¥196.28 Million | CN¥1.18 Billion | ▼ -42.0% |
| 2015 | 0.48x | CN¥148.73 Million | CN¥66.69 Million | CN¥311.94 Million | ▼ -15.9% |
| 2014 | 0.57x | CN¥118.50 Million | CN¥52.00 Million | CN¥209.06 Million | ▼ -52.7% |
| 2013 | 1.20x | CN¥152.53 Million | CN¥-20.60 Million | CN¥127.18 Million | ▼ -25.0% |
| 2012 | 1.60x | CN¥116.50 Million | CN¥44.53 Million | CN¥72.84 Million | ▲ +50.0% |
| 2011 | 1.07x | CN¥156.55 Million | CN¥138.83 Million | CN¥146.82 Million | ▲ +145.3% |
| 2010 | 0.43x | CN¥73.07 Million | CN¥57.02 Million | CN¥168.14 Million | ▲ +1913.7% |
| 2009 | -0.02x | CN¥-3.03 Million | CN¥-26.60 Million | CN¥126.53 Million | ▼ -105.9% |
| 2008 | 0.40x | CN¥46.87 Million | CN¥41.57 Million | CN¥115.74 Million | — |